Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Daniel Neukomm | CSLM CSLM Acquisition Corp. Class A Ordinary Share | 13G | 19.33% | Dec 31, 2023 | 2y |
| Kynam Capital Management, LP | BNR Burning Rock Biotech Ltd | 13G/A | 10.19% | Dec 31, 2023 | 2y |
| HMI Capital Management, L.P. | GTLB Gitlab Inc. | 13G/A | 4.1% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | AMSC American Superconductor Corp | 13G/A | 7.3% | Dec 31, 2023 | 2y |
| Alyeska Investment Group, L.P. | SRZN Surrozen, Inc. | 13G | 9.99% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | SAM Boston Beer Co Inc | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | MGY Magnolia Oil & Gas Corp | 13G | 5.2% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | OBIO Orchestra BioMed Holdings, Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | RGCO Rgc Resources Inc | 13G/A | 0% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | PAYO Payoneer Global Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Halis Family Foundation | SFES Safeguard Scientifics Inc | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | ENTG Entegris Inc | 13G/A | 4.4% | Dec 31, 2023 | 2y |
| V. Gordon Clemons | CRVL Corvel Corp | 13G/A | 7.15% | Dec 31, 2023 | 2y |
| Pfizer Inc | ELVN Enliven Therapeutics, Inc. | 13G/A | 0.95% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | IDYA IDEAYA Biosciences, Inc. | 13G | 5.5% | Dec 31, 2023 | 2y |
| AMERIPRISE FINANCIAL INC | MASS 908 Devices Inc. | 13G | 5.84% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | AVGR Avinger, Inc. Common Stock | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | CSTAF Constellation Acquisition Corp I | 13G/A | 0% | Dec 31, 2023 | 2y |
| Ayrton Capital LLC | PMCB PharmaCyte Biotech, Inc. | 13G | 9.9% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | JMSB John Marshall Bancorp, Inc. | 13G/A | 11% | Dec 31, 2023 | 2y |
| Jeremy M. Levin | OVID Ovid Therapeutics Inc. | 13G/A | 9.4% | Dec 31, 2023 | 2y |
| Robert Martin Friedland | IE Ivanhoe Electric Inc. | 13G | 9% | Dec 31, 2023 | 2y |
| Founders Fund V Management, LLC | AMTI Applied Molecular Transport Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Avoro Capital Advisors LLC | UTHR UNITED THERAPEUTICS Corp | 13G/A | 6.1% | Dec 31, 2023 | 2y |
| Ayrton Capital LLC | PTPI Petros Pharmaceuticals, Inc. | 13G | 9.9% | Dec 31, 2023 | 2y |
| Shay Capital LLC | TLYS Tilly's, Inc. | 13G/A | 8.5% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | SSKN STRATA Skin Sciences, Inc. | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| H/2 CREDIT MANAGER LP | VRE Veris Residential, Inc. | 13G/A | 4.66% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | ZEO Zeo Energy Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Dengrao Jia | GMM Global Mofy AI Ltd | 13G | 7.95% | Dec 31, 2023 | 2y |
| AQR CAPITAL MANAGEMENT LLC | ACAC Acri Capital Acquisition Corporation Class A Common Stock | 13G | 5.48% | Dec 31, 2023 | 2y |
| Aristotle Capital Management, LLC | XYL Xylem Inc. | 13G/A | 3.71% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | MDGL Madrigal Pharmaceuticals, Inc. | 13G/A | 0.25% | Dec 31, 2023 | 2y |
| HG Vora Capital Management, LLC | GBTG Global Business Travel Group, Inc. | 13G/A | 1.7% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | BVFL BV Financial, Inc. | 13G | 9.2% | Dec 31, 2023 | 2y |
| Springhouse Capital Management, LP | WILCF G Willi Food International Ltd | 13G/A | 5.8% | Dec 31, 2023 | 2y |
| RAFFLES ASSOCIATES LP | PROV Provident Financial Holdings Inc | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| CITADEL ADVISORS LLC | DBTX Decibel Therapeutics, Inc. Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | TETWF Technology & Telecommunication Acquisition Corp | 13G | 9.49% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | MGY Magnolia Oil & Gas Corp | 13G/A | 3.4% | Dec 31, 2023 | 2y |
| BOOTHBAY FUND MANAGEMENT, LLC | ECDA ECD Automotive Design, Inc. | 13G/A | 3.1% | Dec 31, 2023 | 2y |
| Atreides Management, LP | ACVA ACV Auctions Inc. | 13G/A | 8.09% | Dec 31, 2023 | 2y |
| AWM Investment Company, Inc. | TBCH Turtle Beach Corp | 13G/A | 6.3% | Dec 31, 2023 | 2y |
| OceanLink Partners Fund, LP | QFIN Qfin Holdings, Inc. | 13G | 5.19% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | RLMD Relmada Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Fundsmith LLP | BF-B Brown Forman Corp | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | LRMR Larimar Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares | 13G | 8.12% | Dec 31, 2023 | 2y |
| MACKENZIE FINANCIAL CORP | TIXT TELUS International (Cda) Inc. Subordinate Voting Shares | 13G/A | 8.76% | Dec 31, 2023 | 2y |
| G1 Execution Services, LLC | BURU Nuburu, Inc. | 13G/A | 0.3% | Dec 31, 2023 | 2y |